JEFF DAVIS — History
CCN 111333 | 3-year financial timeline | COVID resilience: 41/100
🛡️ Public data only — no PHI permitted on this instance.
$21M
Latest Revenue (FY2022)
+4.1%
Revenue CAGR (3yr)
-6.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $19M | $21M | $21M | -2.3% | +4.1% |
| Operating Expenses | $19M | $21M | $22M | +2.7% | +8.5% |
| Operating Margin | 2.1% | -1.2% | -6.3% | -434.7% | +0.0% |
| Net Income | $0M | $-0M | $-1M | -422.6% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 3,359 | 4,156 | 2,443 | -41.2% | -14.7% |
| Medicare Day % | 47% | 25% | 33% | +33.6% | -15.3% |
| Medicaid Day % | 8% | 8% | 20% | +162.0% | +52.8% |
COVID Impact & Recovery
Resilience Score: 41/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +8.4% ($19M → $21M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.1%
This Hospital
+7.6%
State Avg
Latest Margin
-6.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $21M | -10.5% |
| FY2024 (proj) | $22M | -14.7% |
| FY2025 (proj) | $23M | -18.9% |